x

Search for a clinical trial

*(*) mandatory field

4 Result(s)

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

AUSTRIA

WIEN
WIEN

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberHCQ4Surfdefect: Hydroxychloroquine (HCQ) in pediatric ILD (interstitial lung disease) - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Pädiatrische Pulmologie, Allergologie und Endokrinologie

FRANCE

OCCITANIE
TOULOUSE

Hydroxychloroquine as a steroid sparing treatment for non complicated giant cell arteritis.A double blind randomized study (Phase III) - Terminated -
CHU de Toulouse - Hôpital Purpan
Service de Médecine interne - Pôle inflammation, infection, immunologie et loco-moteur